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Abstract
New experimental techniques in epigenomics allow researchers to assay a diversity of
highly dynamic features such as histone marks, DNA modifications or chromatin struc-
ture. The study of their fluctuations should provide insights into gene expression regula-
tion, cell differentiation and disease. The Ensembl project collects and maintains the
Ensembl regulation data resources on epigenetic marks, transcription factor binding and
DNA methylation for human and mouse, as well as microarray probe mappings and an-
notations for a variety of chordate genomes. From this data, we produce a functional an-
notation of the regulatory elements along the human and mouse genomes with plans to
expand to other species as data becomes available. Starting from well-studied cell lines,
we will progressively expand our library of measurements to a greater variety of sam-
ples. Ensembl’s regulation resources provide a central and easy-to-query repository for
reference epigenomes. As with all Ensembl data, it is freely available at http://www.
ensembl.org, from the Perl and REST APIs and from the public Ensembl MySQL database
server at ensembldb.ensembl.org.
Database URL: http://www.ensembl.org
VC The Author(s) 2016. Published by Oxford University Press. Page 1 of 13
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.




 at 20801 Instituto G







In addition to providing long-term storage of genetic infor-
mation across cell divisions, DNA is also a physical molecule
with dynamic biochemical activity. Complex interactions
with polymerases, transcription factors (TF) and enzymes
that modify histones and DNA (1–3) as well as its spatial
structure (4, 5) largely determine the functional activity of the
cell’s chromatin, in particular the controlled transcription of
genes (6), which in turn controls cell development (7).
Variants on the active sites of these interactions, or regulatory
elements (8), have been shown to be driving forces of evolu-
tion (9, 10) and disease (11).
Advances in laboratory assays have allowed us to meas-
ure this rich activity genome-wide. For example, histone
modifications and TF binding locations previously identi-
fied with chromatin immunoprecipitation followed by
microarray hybridisation (ChIP-chip) (12) now generally
employ high-throughput sequencing (ChIP-seq) (13, 14);
DNA methylation is assayed with MeDIP (15) or bisul-
phite sequencing (16); regions of open chromatin are iden-
tified with Formaldehyde-Assisted Isolation of Regulatory
Elements (FAIRE) (17), DNase-seq (18) or ATAC-seq (19).
These measurements can be used to identify regulatory
elements (20–22), but also characterise disease (23). To de-
tect any signal, it is crucial to survey many of these bio-
chemical features, often running many assays on a
considerable number of samples. For this reason, large
consortia have already produced vast reference datasets
(24–26).
To make sense of these large datasets, the Ensembl
Regulation resources provide a rich and powerful framework
to browse or query these data and enable cell types compari-
son. In addition to cell-type specific measurements, we pro-
vide a number of summaries, as well as mapping microarray
probes to the current reference sequences. Alongside all other
Ensembl resources (27–30), this data can be browsed on the
web, but also accessed programmatically through MySQL,
Perl or REST (31) for intensive queries. Finally, a BioMart
server (32) allows users to extract the required data in bulk.
Methods
Uniform processing of epigenomic data
We first select cell types for which we have sufficient data
to produce a segmentation (see below), and download all
the epigenomic datasets associated with those cell types in
the form of sequencing reads.
Since we are aggregating data from diverse sources, it is
vital to remove artefacts due to differences in analysis pipe-
lines. Moreover, scientific consortia generally have neither
the remit nor the resources to update their analysis results
each time the reference assembly or other genome annota-
tion is updated. We therefore remap all of the original data
onto the current reference genome, call peaks and normal-
ise the signal with our uniform pipeline (33).
Regulatory evidence
To assess the experimental evidence supporting the high
level annotation, Ensembl’s regulation resources provide
the underlying peaks and normalised sequence read cover-
age signals. This experimental data comes from various
public datasets (see Table 1). We track its provenance and
provide links to the raw data in primary database resources
such as the European Nucleotide Archive (ENA) (34),
ENCODE (26) or NCBI (25).
Genome segmentation
Genome segmentation tools such as Segway (35) or
ChromHMM (36) conveniently allow us to summarise mul-
tiple assays into a single annotation of the genome.
Essentially, they cluster genomic regions by their associated
experimental marks. They can thus replace multidimensional
measurements with cluster identifiers, or states. For human,
we provide Segway and ChromHMM segmentations of our
Table 1. Ensembl regulation experimental resources for release 77
Experimental resources




Human ENCODE: 423 Polymerase: 23 2 Experimental peaks: 11267991
Roadmap Epigenomics: 62 Histone mod: 241 46
Other: 22 TF: 196 213 Motif Features: 154884
Total: 507 Open Chromatin: 25 2
Mouse ENCODE: 16 Polymerase: 5 1 Experimental Peaks: 1016365
Other: 57 Histone mod: 26 12
Total: 73 TF: 29 24 Motif features: 126617
Open Chromatin: 3 1
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Figure 1. Regulation tracks. Screenshot of the ‘Region in detail’ location view, upstream of the human TP53 gene. The default ‘MultiCell’ regulatory
features track is shown. Below, the regulatory features, segmentation, ‘TFBS & DNase1’ and ‘Histones and Polymerases’ tracks associated to cell
type GM12878. Finally, below again, the regulatory features annotated with activity for a few other cell types. Features that are inactive in a specific
cell type are greyed out. Various elements were clicked to reveal floating menus with feature specific data and links to detailed views or external
resources.
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data, in which we replace the state identifier numbers with
more evocative functional labels: predicted promoter with
TSS, predicted transcribed region, predicted promoter flank,
predicted enhancer, CTCF enriched, predicted repressed, pre-
dicted low activity and predicted heterochromatin.
The Ensembl regulatory build
The Ensembl Regulatory Build has been redesigned to pro-
vide a straightforward summary of all the data processed
above (33) (Figure 1). It is composed of consensus features
(called MultiCell in the interface) that describe the func-
tion of a region. These functional labels are either inferred
from the segmentation (promoter with TSS, promoter
flanking region, distal enhancer or CTCF binding site) or
directly from experimental measurements that are not ex-
plained by the segmentation (unannotated TF binding site–
TFBS–or unannotated open chromatin). Each MultiCell
feature is annotated with a cell type specific activity indica-
tor (active or inactive).
Motif features
Chromatin immunoprecipitation experiments locate gen-
omic fragments bound by a protein. Nonetheless, they do
not directly locate the exact TFBS at nucleotide resolution.
We therefore annotate TF binding peaks with overlapping
motif features, i.e. putative TFBS based on existing pub-
licly TFBS Position Weight Matrices (PWM) from JASPAR
(37).
We start by associating TFs used in ChIP experiments
to Ensembl gene IDs based on the antibody used in the
ChIP experiment. We then associate each JASPAR matrix
to Ensembl genes. If the JASPAR protein identifier is from
the correct species, this is done directly using Ensembl’s
database of cross-linked identifiers across bioinformatics
resources. Otherwise, the matrix is associated to the
Ensembl human gene with the best Blastp (38) alignment
to the JASPAR protein (blastp version: 2.2.15, parameters:
-M BLOSUM80 -m 8 -b 1 –i). This process allows us to use
any metazoan PWM for human and maximise the number
of TFs covered.
To annotate TFBSs, we start by taking all JASPAR TF
PWMs and do a lenient whole genome search for motif
matches using MOODS (39). We then select all the
matches that lie within observed ChIP-seq binding regions.
We discard any match whose score has a single tail p-value
above 5%, as estimated empirically from the distribution
of scores obtained by selecting matches on random regions
of the genome. Finally, we associate filtered matches to
overlapping experimental features and their associated
regulatory feature.
Of the 211 human TFs for which we have experimental
data, 45 have at least one associated PWM (in total, 97
PWMs are associated, see Supplementary Table 1).
Ensembl release 77 (October 2014) includes 154 884 dis-
tinct TFBS for human. Similarly, of the 23 mouse TFs for
which we have experimental data, 12 have an associated
PWM (19 PWMs in total, see Supplementary Table 2).
They are associated to 126 617 TFBS. Note that not all
TFs have an associated PWM in JASPAR. The fraction of
peaks with an associated motif hit, assuming a PWM is
known, is highly variable (see table S3), however for strong
binding pioneer TFs such as CTCF a PWM is found at a
substantial majority of binding sites.
DNA methylation
Both Reduced Representation and Whole Genome Bisulfite
Sequencing (RRBS/WGBS) data (16, 25, 26, 40) are provided
via the database, characterising 44 cell lines. This data was
processed with Bismark (41) with default parameters, and
replicate counts were merged. The number of converted reads
at each position was fitted to a mixture model of two beta-bi-
nomial distributions and a uniform discrete distribution con-
ditioned on the total number of reads at that position. This
model assumes that a base pair is fully methylated, fully
unmethylated or in an undetermined third state. For each
dataset, the parameters of these distributions were set by
Expectation Maximization (EM) across all the data points.
See Figure 2 for an example fit. Using these parameters, we
evaluated the posterior probability of all three states at each
Figure 2. Modelling bisulphite sequencing results with a Bayesian
model. The fraction of converted reads in bisulphite sequencing is cor-
related to the methylation status of the underlying DNA. We show here
a Bayesian model that fits the observed data by dividing the cytosines
into three categories: methylated (red), unmethylated (blue) and un-
known (green).
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observed position. If all three states had a posterior probabil-
ity>104, then the position was discarded.
Externally curated data
Ensembl stores a small set of externally curated datasets
pertinent to gene regulation. These include: a set of human
and mouse miRNA target predictions provided by
DIANA-TarBase (42), experimentally validated non-cod-
ing regions from the VISTA enhancer browser (43), and re-
gions highlighted by the FANTOM 5 project (44, 45).
Microarray probe mappings
Microarray probe mappings are provided for widely used
microarray platforms across several species. See
Supplementary Table S4 for a summary of the supported
platforms. These are primarily expression arrays, with a
smaller number of human methylation and comparative
genomic hybridization (CGH) arrays. Represented manu-
facturers include Affymetrix, Illumina, Codelink, Agilent
and Phalanx, as well as small number of custom array de-
signs. Our methods for mapping probes and the resulting
annotations were described in Ballester et al. (46).
Experimental metadata
Normalised annotation of experimental metadata (such as
the cell type and experimental factor) is essential for data
integration. Large-scale projects such as ENCODE
have led the way by using internal stable nomenclatures.
To improve traceability and data integration, we use the
Figure 3. Configuration panel and data selection matrix. This panel is available via the ‘Configure this page’ button in the location view. The
‘Regulation’ menu items describe the different types of data available. Lower down, the ‘Oligo Probes’ menu items provides access to microarray
probe mappings.
The ‘Open chromatin & TFBS’ item has been selected to reveal a configuration matrix. To assist first time users, a tutorial is presented, this tutorial
can be hidden or shown as desired.
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Experimental Factor Ontology (EFO) (47), and actively
work with the EFO curation team to correct or submit new
entries as required.
Data visualisation and access
Ensembl location view
Ensembl regulation data can be visualised in the Ensembl
genome browser (48). Figure 1 shows an example of the
main Location view, where regulatory features can be
observed alongside gene models and other user-selected
data. Clicking on a regulatory feature reveals a pop-up
menu with basic details: feature coordinates, stable ID, its
classification and mapped TF binding motifs. By default,
only the MultiCell regulatory features are displayed in this
view, but the display can configured to show additional
cell-specific annotations and regulatory evidence using the
configuration panel linked on the left hand side of the
page.
Experimental evidence for the MultiCell regulatory fea-
tures can be displayed as regions, generally ChIP-seq peak
calls. Clicking on a peak displays its type (e.g. DNase1 or the
specific TF name); the parameters that defined the region
from the data including score and peak summit representing
the position of highest sequencing read coverage; and a data
source such as an ENA accession. Additionally, the read
coverage density functions underlying the peaks, measured in
Reads Per Kilobase per Million mapped reads (RPKM), can
be displayed as curves.
Motif features (PWM alignments) are displayed as
black boxes within regulatory features and ChIP-seq peaks
of the corresponding TF. Clicking on a motif feature re-
veals a floating menu where the TF name, JASPAR PWM
ID and the ratio of the motif’s binding score divided by the
PWM’s optimal binding affinity are all highlighted within
a Motif Information table.
The regulatory segmentation data is shown as a con-
tinuous line across the genome whose colour changes with
the local classification. Clicking on a segment reveals its
classification, its exact genomic location, and the analysis
used to generate the segmentation.
DNA CpG methylation can be displayed as markers,
whose color moves along a gradient from yellow (hypo-
methylated) through to green then blue (hyper-methy-
lated). A click reveals the methylation information for any
given cytosine, when zoomed out these changes to provid-
ing summary information for the selected region.
Other externally curated sets of functional elements (ex-
pression quantitative trait locus–eQTL–regions, miRNA
targets and VISTA regions) can also be displayed as feature
tracks, with appropriately detailed feature menus.
Configuring the location view
The Regulation tracks can be configured in the
‘Regulation’ section of the display configuration panel
Figure 4. Regulatory Feature ‘Summary’ view. This view displays the
genes overlapped by the regulatory element of interest, along with ac-
tivity information in all available cell types. In this case, the red pro-
moter is constitutively active, but the nearby cyan CTCF binding site is
active in only 4 cell types.
Page 6 of 13 Database, Vol. 2016, Article ID bav119
 at 20801 Instituto G






Figure 5. Regulatory feature ‘Details by cell line’ view. This view displays all the evidence surrounding a regulatory feature of interest, either as re-
gions (ChIP-seq peaks) or signal functions. At the top, a solid multicolored bar represents the segmentation for the desired cell types. Note the se-
lector buttons above the window.
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(Figure 3). The submenu items restrict the panel to subsets
of available tracks.
Because of the large number of available cell types and ex-
periments, many of the experimental tracks are organised in
tables where each column is specific to a cell type and each
row to a type of assay. A search box facilitates filtering the
list of available factors. Clicking or dragging the mouse se-
lects single or multiple tracks. Pointing the mouse above an
axis label reveals a button to select or deselect all the cells on
that row or column. For each column, the user can choose
between displaying regions (peaks), or plots of sequencing
read coverage depth (signal).
The display of microarray probe mappings can be config-
ured from the top-level ‘Oligo Probe’ section in the configur-
ation menu.
Inspecting a regulatory feature
Clicking on a regulatory feature stable ID leads to a
‘Regulation’ tab, where more detailed information is dis-
played about that feature, including cell-specific annota-
tions and supporting regulatory evidence that are usually
not displayed in the Location view. On the top of the
screen, large icons lead to different displays. Each display
starts with the location of the feature and a summary of its
activity in each cell type, followed by a specialised view:
Summary: a lightweight view that displays the ’MultiCell’
regulatory feature and its activity in different cell types
(see Figure 4).
Details by cell line: Cell-specific features are shown along-
side their supporting evidence (Figure 5). To aid inter-
pretation, vertical red lines delineate the core region of
the selected regulatory feature. Buttons at the top of the
display bring up modal windows to quickly toggle cell
types and experimental evidence on or off (see Figure 6).
Feature Context: A display of wider genomic context
around the chosen regulatory feature (see Figure 7).
Evidence: A tabular view displaying the list of all support-
ing evidence peaks for that regulatory feature. The table
header allows the user to filter and export the table.
Example use case
The applications of this regulatory annotation are expected
to expand with time. Key current uses include prioritising
regulatory variants and observing the dynamics of gene ex-
pression regulation. For example, oestrogen receptor gene
ESR1 is known to have an alternate distal promoter in
osteoblasts and some cancer cell lines (49). This alternate
promoter is clearly identified in the Regulatory Build, as
shown in Figure S5.
Experimental Meta-data
Tracking the origin of experimental evidence is essential
for traceability and reproducibility. We store experimental
meta-data in the Ensembl ‘Funcgen’ database, and these
Figure 6. Regulatory Feature ‘Details by cell line’, cell type and experimental evidence selectors. (A) At the top of the ‘Details by cell line view’ (Figure
5) a button labelled ‘Select cells’ displays this modal window, which allows the user to quickly toggle cell types on or off. (B) Similarly, the ‘Select evi-
dence’ button displays this modal window, which allows the user to quickly toggle experimental tracks on or off.
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data can be accessed through the browser. Selecting an ex-
perimental peak reveals a link to the original data. This
link is labelled with either a sequence archive ID (referring
to the exact set of sequencing reads used in the Ensembl
analysis) or a project name such as ENCODE if the data
has not yet been submitted or deposited in an archive.
Selecting this link leads to an Experiment view, containing
a summary table of all available experiments, and a more
detailed Sources table describing the sources of the selected
feature. The summary table can be used to filter the con-
tent of the detailed Sources panel, allowing easy access and
comparison of the meta-data for all the experiments incor-
porated into the Regulatory Build. By clicking links in the
summary table, filters on cell type, project name and evi-
dence type can be added or removed. The system automat-
ically composes the filters to display the desired datasets.
In the Sources table, the ‘source’ and ‘project’ fields link
out to the location of the source data (either in a sequence
archive or on an associated project page) and the project
website respectively. Other fields here include evidence
type and name, links to the cell type EFO definition,
PWMs and associated encoding genes for TF experiments.
More fine-grained filtering is again enabled in the table
header search box, allowing searches for more specific fea-
ture types.
BioMart
Large-scale querying of Ensembl regulation data is possible
through the Ensembl BioMart interface (32), which can
output large numbers of features in several formats includ-
ing tab-delimited text. Using the ‘Ensembl Regulation’
database (see Figure 8) as a starting point the user can se-
lect a regulation data set for a given species. The human
and mouse data sets contain regulatory features, as well as
regulatory evidence (experimental peaks), binding motifs
(TFBS PWM mappings) and other regulatory regions (ex-
ternally curated data). The Drosophila data set currently
contains the latter only.
Using filters, data for specific cell lines and/or specific
experimental factors can be selected as can regulatory fea-
tures overlapping specific genomic regions (e.g. upstream
genes of interest).
Microarray probe mappings and transcript annotations
can be obtained through the ‘Ensembl Genes’ database, by se-
lecting the relevant array related filters or external attributes.
Methylation data are not currently available through
BioMart.
Within the Variant Effect Predictor
The Ensembl Variant Effect Predictor (VEP) (50) has re-
cently added regulatory features to its set of predicted
Figure 7. Regulatory Feature ‘Feature context view’. This view displays
the general context 25 kb upstream and downstream of a feature, with
genes and neighbouring elements. As in the summary view, for each
cell type inactive features are greyed out, with sparse coloured lines
indicating their underlying function. At the bottom, FANTOM5 elements
and TarBase target regions are indicated.
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consequences that can be associated with single nucleotide
polymorphisms (SNP) or de novo variants. This provides
an additional source of evidence for the effect of variants
that, although significantly associated to diseases or other
phenotypes, have currently little functional annotation
since they often fall outside known coding regions. The
VEP also reports whether a variant falls in a TFBS binding
motif and, in the case of SNPs, whether it lies in a highly
informative position of the TFBS, with potentially signifi-
cant effects on the TF binding affinity (see Figure 9).
Programmatic data access
As with other Ensembl resources, regulation data can be ex-
tracted using a specific Perl Application Programming
Interface (API) or by directly accessing the public funcgen
MySQL databases at ensembldb.ensembl.org. The Ensembl
website hosts specific funcgen tutorials and documentation
describing this access (http://www.ensembl.org/info/docs/
funcgen/index.html). For other programming languages,
key extraction functions are offered via the RESTful inter-
face (31).
Data downloads
Ensembl regulation data is also available for download on
the FTP site (http://www.ensembl.org/info/data/ftp/index.
html). This includes separate GFF files for each cell specific
and MultiCell Regulatory Build (RegulatoryFeatures), as
well as supporting experimental evidence (Annotated
Features) and PWM alignments (MotifFeatures).
Discussion
The Ensembl regulation resources will continue to grow
and evolve, accompanying the fields of genome regulation
and epigenomics as new results are produced and new ex-
perimental techniques and analyses are developed. Firstly,
in terms of scale, we expect the number of available cell
types to climb rapidly to the hundreds, as more groups are
contributing epigenomes to the global research community
via the International Human Epigenome Consortium
(IHEC) and other efforts. In particular, tissue samples will
progressively replace the cell line models used thus far,
which will enable us to detect regulatory features with
greater sensitivity, since we are likely missing a consider-
able number of dynamic tissue-specific elements such as
enhancers.
Since our focus is to provide complete cell type specific
annotations, we cover only chosen cell types, and do not
attempt to include all publicly available epigenomic data-
sets. These data can nonetheless be visualised in Ensembl
using, for example, the IHEC data portal’s track hub func-
tion (http://epigenomesportal.ca/ihec/).
Figure 8. Constructing a BioMart query. This figure exemplifies the construction of a BioMart query to obtain all regulatory features for K562, within the
region 1:1000 000–10 000 000 and display a varied number of properties for those regulatory regions, including their stable ids.
Figure 9. VEP output using motif feature information. Subsection of the VEP report on SNP rs694061. The VEP reports whether a SNP affects the bind-
ing affinity of a motif feature (i.e. whether position of the SNP contains at least 1.5 bits of information on the PWM).
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Our limited knowledge of TF binding motifs will need to
be addressed. Current public databases such as JASPAR (37)
only cover a fraction of existing TFs. Other techniques such
as UniPROBE (51) or SELEX (52) will allow us to describe
far richer binding interactions at enhancer and promoter
sites.
New technologies, such as chromatin conformation cap-
ture (53–55) will add a spatial component to our datasets.
This might in turn affect analysis tools, such as segmenta-
tion, which could take into account spatial proximity when
computing state likelihoods (56).
There will also be attempts to describe the cis-
interactions of the regulatory elements thus uncovered.
Already, signal correlation (43, 57), eQTLS (58, 59) and
chromatin conformation capture (60) are being improved
to eventually produce a map of the regulatory network of
the genome. As these approaches are refined, they will sig-
nificantly enrich the annotations of the features defined by
the Ensembl Regulatory Build.
Conclusion
Ensembl’s regulation resources aim to document all the
available knowledge on gene expression regulation and
epigenomics. We are progressively accumulating data on
as many cell types as possible, describing histone marks,
transcription factor binding, DNA modifications and tran-
scription factor binding motifs. Much like the research
field it is serving, this resource is still in an expansion phase
and resolutely turned towards new experimental
techniques.
Availability
All Ensembl data and source code are freely available and
may be downloaded in their entirety from the Ensembl
website. Each Ensembl release is maintained as an archive
web site for at least 3 years after the date of initial release.
Ensembl is updated approximately five times each year
with new data, genome assemblies, and sequenced gen-
omes. Additionally, the data is available through a pro-
grammatic interface and through the web-based Ensembl
Biomart.
Supplementary Data
Supplementary data are available at Database Online.
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